Factorial Designs. Background Factorial designs are when different treatments are evaluated within the same randomised trial. A factorial design has a.

Slides:



Advertisements
Similar presentations
Inferential Statistics and t - tests
Advertisements

Patient Preference and Comprehensive Cohort Designs.
Unequal Randomisation
Use of Placebos in Controlled Trials. Background The traditional ‘double-blind’ RCT uses a placebo to conceal allocation. There are a number of advantages.
Meta-analysis: summarising data for two arm trials and other simple outcome studies Steff Lewis statistician.
Sample size issues & Trial Quality David Torgerson.
Observational Studies and RCT Libby Brewin. What are the 3 types of observational studies? Cross-sectional studies Case-control Cohort.
Reporting drugs and treatments Thomas Abraham. What we will learn today The difference between absolute and relative risk reduction A basic way to interpret.
The Bahrain Branch of the UK Cochrane Centre In Collaboration with Reyada Training & Management Consultancy, Dubai-UAE Cochrane Collaboration and Systematic.
Pre-analysis plans Module 8.3. Recap on statistics If we find a result is significant at the 5% level, what does this mean? – there is a 5% or less probability.
Improving the Economic Efficiency of Clinical Trials.
1 Case-Control Study Design Two groups are selected, one of people with the disease (cases), and the other of people with the same general characteristics.
Recruitment to Trials. Background Recruitment of participants is a VERY important issue. The general consensus is that most trials under recuit.
Management of Acute Myocardial Infarction Minimal Acceptable vs Optimal Care Hussien H. Rizk, MD Cairo University.
Statistical Power. H o : Treatments A and B the same H A : Treatments A and B different.
EBM - Background A Canadian connection! – The term "evidence based medicine" was coined at McMaster University’s Medical School in the 1980's to label.
N = 1, Cross-Over Trials and Balanced Designs. N = 1 Trials Trials can be undertaken with just one participant. If the condition is a chronic relapsing.
2: Types of Studies1. 2 In Chapter 2: 2.1 Surveys 2.2 Comparative Studies.
Pragmatic Randomised Trials. Background Many clinical trials take place in artificial conditions that do not represent NORMAL clinical practice. Often.
Pre-randomisation consent (Zelen’s method)
Calcium/Vitamin D-related CV Events Based on Poster 1163 “Risk of Cardiovascular Events with Calcium/Vitamin D – a Re-Analysis of the Women’s Health Initiative”
Should we??. Aspirin is useful! It is widely used in secondary prevention It reduces the yearly risk of vascular events by about a quarter This corresponds.
The Bahrain Branch of the UK Cochrane Centre In Collaboration with Reyada Training & Management Consultancy, Dubai-UAE Cochrane Collaboration and Systematic.
1 Therapies Not Indicated Andrew P. DeFilippis, Ty J. Gluckman, James Mudd, Catherine Campbell, Gregg Fonarow & Roger S. Blumenthal.
Linda Snetselaar, PhD, RD Professor Interim Chair of the Department of Community and Behavioral Health College of Public Health University of Iowa.
Research Design Interactive Presentation Interactive Presentation
Multiple Choice Questions for discussion
A Comparison of the Effectiveness of Estrogen-Progesterone and Estrogen-Testosterone Combination Therapies in the Prevention of Osteoporosis in Postmenopausal.
Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.
BIOE 301 Lecture Seventeen. Guest Speaker Jay Brollier World Camp Malawi.
Journal Club Hallie Lee PharmD Candidate 2013 Mercer University COPHS PHA 618 Geriatrics-Continuous Care Multivitamins in the Prevention of Cardiovascular.
EVIDENCE BASED MEDICINE Effectiveness of therapy Ross Lawrenson.
How to Analyze Therapy in the Medical Literature (part 2)
EBCP. Random vs Systemic error Random error: errors in measurement that lead to measured values being inconsistent when repeated measures are taken. Ie:
Research Methods In Psychology Mrs. Andrews. Psychology… The scientific study of behavior and mental processes.
Published in Circulation 2003 Rory Hachamovitch, MD, MSc; Sean W. Hayes, MD; John D. Friedman, MD; Ishac Cohen PhD; Daniel S. Berman, MD Comparison of.
LIPID: Long-term Intervention with Pravastatin in Ischemic Disease Purpose To determine whether pravastatin will reduce coronary mortality and morbidity.
BIOE 301 Lecture Seventeen. Progression of Heart Disease High Blood Pressure High Cholesterol Levels Atherosclerosis Ischemia Heart Attack Heart Failure.
HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.
EXPERIMENTAL EPIDEMIOLOGY
Causal relationships, bias, and research designs Professor Anthony DiGirolamo.
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288:
Objectives  Identify the key elements of a good randomised controlled study  To clarify the process of meta analysis and developing a systematic review.
The Practice of Statistics, 5th Edition Starnes, Tabor, Yates, Moore Bedford Freeman Worth Publishers CHAPTER 4 Designing Studies 4.2Experiments.
How To Design a Clinical Trial
The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. N Engl J Med 2006; available at: End pointActive therapy PlaceboRelative.
Copyright © 2013, 2009, and 2007, Pearson Education, Inc. Chapter 10 Comparing Two Groups Section 10.1 Categorical Response: Comparing Two Proportions.
Compliance Original Study Design Randomised Surgical care Medical care.
Types of Studies. Aim of epidemiological studies To determine distribution of disease To examine determinants of a disease To judge whether a given exposure.
Long-Term Tolerability of Ticagrelor for Secondary Prevention: Insights from PEGASUS-TIMI 54 Trial Marc P. Bonaca, MD, MPH on behalf of the PEGASUS-TIMI.
Long-Term Tolerability of Ticagrelor for Secondary Prevention: Insights from PEGASUS-TIMI 54 Trial Marc P. Bonaca, MD, MPH on behalf of the PEGASUS-TIMI.
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
What are the Chances Dr? Nick Pendleton. Can I have a Prostate Check? ?
Copyright ©2011 Brooks/Cole, Cengage Learning Gathering Useful Data for Examining Relationships Observation VS Experiment Chapter 6 1.
The ALERT Trial.
Brady Et Al., "sequential compression device compliance in postoperative obstetrics and gynecology patients", obstetrics and gynecology, vol. 125, no.
Statistics in Clinical Trials: Key Concepts
Robert West University College London London March 2008
Confidence Intervals and p-values
HOPE: Heart Outcomes Prevention Evaluation study
Article & Final Reviews
The Anglo Scandinavian Cardiac Outcomes Trial
Research Design & Analysis II: Class 10
FATS- Familial Atherosclerosis Treatment Study
Baseline characteristics of HPS participants by prior diabetes
NOACS: Emerging data in ACS/IHD
Statistical Reasoning December 8, 2015 Chapter 6.2
LRC-CPPT and MRFIT Content Points:
Evidence Based Practice
The Research Question Background: Question:
Presentation transcript:

Factorial Designs

Background Factorial designs are when different treatments are evaluated within the same randomised trial. A factorial design has a number of important advantages.

Advantages Two trials for the price of one. Can test for an ‘interaction’ between treatments – does a treatment work even better in the presence of another therapy?

Disadvantages Can be more complicated to undertake leading to a higher potential for error. Interactions can mean some of the sample is lost, which will reduce power for main comparisons.

Example Waters et al. Examined the use of HRT and antioxidant vitamins for treatment of coronary heart disease. Observational data suggest a benefit of HRT and antioxidant vitamins. Sensible to examine effects of both.

Factorial Design HRT and Placebo Vitamins HRT and Vitamins Placebo HRT VitaminsVitamins + Placebo HRT

Analysis The analysis treats the study as two separate trials. All women who got HRT would be compared with those who did not. Likewise all those given vitamins would be compared with who were not given vitamins.

HRT and Vitamin Trial Over 400 women randomise to the 4 treatment arms. Outcomes included surrogate measures (lipid levels angiograms) plus ‘real’ outcomes – death MIs.

Results Both treatments INCREASED the risk of MI and death. NO interaction with treatments suggesting that the risk of death is additive.

WAVE Trial This trial showed YET AGAIN the harmful effect of HRT AND antioxidant vitamins.

RECORD TRIAL RECORD trial is a factorial trial of calcium with or without vitamin D. Key question is whether vitamin D is effective alone or NEEDS calcium to work. Factorial design is specified to look for an interaction.

Record Trial The interaction is important because there are biologically plausible reasons for both treatments to work better in the presence of each other (I.e a positive interaction). Because vitamin D is so inexpensive it is important to know if this effective on its own.

More complications Basic factorial is 2 X 2 but can be increased by infinite number of factors. UK BEAM trial (backpain) uses a 3 x 2 factorial to test: exercise; GP care; manipulation; exercise plus manipulation. Did include another factor making it a 3 x 2 x 2 design.

BEAM trial Factorial design enabled exercise and manipulation questions to be answered in the same trial. Also enables us to look for interactions between treatments.

Factorial Questionnaire Trial Puffer et al undertook a factorial trial comparing single sided questionnaires vs double with one large questionnaire vs 3 separate questionnaires. Outcome was response rates.

Underuse of Factorial trials Factorial trials could be more widely used as they can answer two questions within the same trial, particularly if there is no reason to suspect an interaction. Factorial trials also enable us to ‘tease’ out the different treatment effects. For example, fall prevention programmes are multifactorial and in standard trial we end up not knowing what produces the main effects.

Systematic Review of Factorial Trials Are interactions common in factorial trials? A review of 44 trials found only 1 trial where an interaction would have given the ‘wrong’ answer and 7 trials where there were indications of an interaction (only 2 were statistically significant). Interactions are relatively unusual and therefore factorial trials are probably an efficient trial approach. McAlister et al. JAMA 2003;289:2545.

Split plot design A split plot design is a special form of factorial design, which mixes cluster and individual randomisation.

SAPPHIRE: example of a split plot design.

Analysis of split plot The same as for a factorial. Will be treated as two separate trials. Again giving us two trials for the price of one.

Summary Factorial trials could and should be more widely used. Caution if there is a chance of a negative interaction one may need to avoid them. Can be administratively more difficult.